Stockscreener 앱 받기
22.38
3.79%
-0.8569
전일 마감가:
$23.24
열려 있는:
$22.51
하루 거래량:
105.97K
Relative Volume:
0.31
시가총액:
$1.31B
수익:
$83.72M
순이익/손실:
$-143.89M
주가수익비율:
-7.9576
EPS:
-2.8128
순현금흐름:
$-120.48M
1주 성능:
-7.53%
1개월 성능:
+12.19%
6개월 성능:
-5.25%
1년 성능:
+34.46%
1일 변동 폭
$22.33
$23.13
1주일 범위
$21.03
$26.52
52주 변동 폭
$14.10
$30.00
Kestra Medical Technologies Ltd Stock (KMTS) Company Profile
명칭
Kestra Medical Technologies Ltd
전화
(425) 279-8002
주소
3933 LAKE WASHINGTON BLVD NE, KIRKLAND
Compare KMTS vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KMTS
Kestra Medical Technologies Ltd
|
22.43 | 1.36B | 83.72M | -143.89M | -120.48M | -2.8128 |
ISRG
Intuitive Surgical Inc
|
357.46 | 125.08B | 11.03B | 3.16B | 2.83B | 8.7254 |
BDX
Becton Dickinson Co
|
153.99 | 42.57B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
39.62 | 32.88B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.95 | 34.16B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
196.26 | 28.81B | 5.54B | 1.52B | 1.74B | 10.37 |
Kestra Medical Technologies Ltd Stock (KMTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-18 | 개시 | BTIG Research | Buy |
| 2025-03-31 | 개시 | BofA Securities | Buy |
| 2025-03-31 | 개시 | Goldman | Neutral |
| 2025-03-31 | 개시 | Piper Sandler | Overweight |
| 2025-03-31 | 개시 | Stifel | Buy |
| 2025-03-31 | 개시 | Wells Fargo | Overweight |
| 2025-03-31 | 개시 | Wolfe Research | Outperform |
모두보기
Kestra Medical Technologies Ltd 주식(KMTS)의 최신 뉴스
Kestra Medical Technologies (NASDAQ:KMTS) Coverage Initiated at Oppenheimer - MarketBeat
Oppenheimer Initiates Kestra Medical at Market Perform - Moomoo
Goodwin Guides IP For Pharmakon On Up To $200 Million Financing For Kestra Medical Technologies - Mondaq
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Kestra Medical Technologies, Ltd. (KMTS) reports Q4 loss, tops revenue estimates - MSN
Kestra Medical Technologies Insider Sold Shares Worth $336,609, According to a Recent SEC Filing - Moomoo
Form 4 Kestra Medical Technologies Inc For: 17 July By Investing.com - Investing.com Nigeria
Wall Street Zen Downgrades Kestra Medical Technologies (NASDAQ:KMTS) to Sell - MarketBeat
Kestra Medical Technologies CEO Webster sells $336,609 in stock - Investing.com UK
Kestra Medical CEO Brian Daniel Webster sells USD 333,745 of common shares - Bitget
Form 4 Kestra Medical Technologies Inc For: 17 July - Investing.com India
Kestra Medical Technologies (KMTS) awards 39,113 shares to its CBO - Stock Titan
Kestra Medical Technologies (KMTS) CCO awarded 58,832 performance-based shares - Stock Titan
Kestra Medical Technologies CEO Webster sells $336,609 in stock By Investing.com - Investing.com UK
Kestra Medical (KMTS) CFO receives 44,118 performance-based shares - Stock Titan
Kestra Medical (KMTS) counsel earns 58,832-share stock award - Stock Titan
Kestra Medical Technologies, Ltd. Common Stock (NASDAQ: KMTS) Stock Price, News & Analysis - Kalkine
A Quick Look at Today's Ratings for Kestra Medical Technologies(KMTS.US), With a Forecast Between $30 to $32 - Moomoo
Analysts Offer Insights on NA Companies: Janus Living, Inc. Class A (JAN) and Kestra Medical Technologies Ltd. (KMTS) - The Globe and Mail
Kestra Medical Technologies Earnings Call Highlights Rapid Growth - TipRanks
Kestra Medical Technologies (KMTS) Could Be 31% Overvalued As Earnings And 2027 Guidance Land - simplywall.st
Akin, an Elite Global Law Firm - akingump.com
Kestra Medical Technologies Inc Outlook FY Re - Moomoo
Kestra Medical (NASDAQ: KMTS) investor Brian Webster plans 15,000-share sale - Stock Titan
Kestra Medical Technologies, Ltd. Stock 12‑Month Price Target Raised to $28.43, Implies 18% Upside - TradingView
Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Down 8.7% After Earnings Miss - MarketBeat
Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Expected to Rise, BTIG Research Analyst Says - MarketBeat
Kestra Medical Technologies secures USD 200M of non-dilutive financing - Medical Buyer
Kestra Medical Technologies, Ltd. Stock 12‑Month Price Target Cut to $27.5, Implies 14% Upside - TradingView
Kestra Medical Technologies Reports Strong Fiscal 2026 Growth - TipRanks
KMTS SWOT Analysis: Key Insights from 10-K Filing - GuruFocus
Earnings call transcript: Kestra Medical posts strong Q4 2026 sales, misses EPS - Investing.com Canada
Kestra Medical secures $75M loan facility with Pharmakon - Investing.com UK
Kestra Medical (KMTS) Q4 2026 Earnings Call Transcript - The Motley Fool
Kestra Medical Technologies Q4 2026 Earnings Call Transcript - MarketBeat
Kestra Medical Technologies (KMTS) Reports Strong Q4 Fiscal 2026 Earnings - GuruFocus
Kestra FY27 outlook set at $137M as Q4 revenue jumps 66% - scanx.trade
Kestra Medical secures $75M loan facility with Pharmakon By Investing.com - Investing.com South Africa
Kestra Medical Technologies Q4 Earnings Call Highlights - MarketBeat
Kestra Medical (NASDAQ: KMTS) targets $24B wearable defibrillator market - Stock Titan
KESTRA MEDICAL TECHNOLOGIES, LTD. FY 2026: Revenue $95.1M, Net income $(131.6M) — 10-K Summary - TradingView
Kestra Medical Technologies : Annual Report for Fiscal Year Ending April 30, 2026 (Form 10-K) - marketscreener.com
Kestra Medical Technologies, Ltd. (KMTS) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Kestra Medical Secures Up to $200 Million in Financing From Pharmakon Advisors - marketscreener.com
Kestra Medical Technologies Ltd reports results for the quarter ended April 30Earnings Summary - TradingView
Kemetics (KMTS) Forecasts Significant Revenue Growth for FY27 - GuruFocus
KMTS: Rapidly scaling cardiac care platform addresses a $10B market with proven outcomes and expanding margins - TradingView
Kestra Medical tops Q4 revenue estimates, but posts wider loss than expected - Investing.com
Kestra Medical tops Q4 revenue estimates, but posts wider loss than expected By Investing.com - Investing.com India
Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing - The Manila Times
Kestra Medical Technologies Secures Up to $200 Million Five-Year Term Loan From BioPharma Credit Funds - TradingView
Kestra Medical Technologies Ltd (KMTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.41%
0.18%
자본화:
|
볼륨(24시간):